Skip to main content
Farmacosmo logo

Farmacosmo — Investor Relations & Filings

Ticker · ZJ1 ISIN · IT0005487670 LEI · 815600ABEDB6F0BDDE28 XMIL Wholesale and retail trade
Open in API
Filings indexed 188 across all filing types
Latest filing 2023-01-05 Director's Dealing
Country IT Italy
Listing XMIL ZJ1

About Farmacosmo

https://www.farmacosmo.com/

Farmacosmo is an e-commerce company that operates an online platform for health, beauty, and personal care products. The company's core business is the online sale of a broad range of items, including parapharmaceuticals, supplements, cosmetics, personal care products, baby supplies, and pet care essentials. Managing its platform in-house, Farmacosmo offers a catalog of over 80,000 products from various brands. The company aims to provide a comprehensive wellness destination by combining the offerings of a pharmacy and a cosmetics retailer, supported by expert advice from professionals.

Recent filings

Filing Released Lang Actions
Farmacosmo - Gargiulo&Maiello - Internal Dealing
Director's Dealing Classification · 98% confidence The document is a formal notification originating from Euronext Growth Milan, dated January 5, 2023. The key fields are 'Oggetto' (Subject) which states 'Dealing' and mentions 'Gargiulo&Maiello - Internal'. Furthermore, the main body title is 'Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.' This structure and content directly correspond to the reporting requirements for insider transactions or director's dealings. This matches the definition for Director's Dealing (DIRS). The document is a notification/template for reporting a transaction, not the transaction itself, but DIRS is the most specific category for this type of insider report.
2023-01-05 English
Farmacosmo - Fabio de Concilio - Internal Dealing
Director's Dealing Classification · 100% confidence The document is a formal notification published on January 4, 2023, under the heading 'Informazione Regolamentata' (Regulated Information). The 'Oggetto' (Subject) is explicitly stated as 'Dealing'. Furthermore, the template used is titled 'Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.' This content directly corresponds to the definition of Director's Dealing (insider trades by executives/directors). This matches the definition for Director's Dealing (Code: DIRS).
2023-01-04 Italian
Farmacosmo - Fabio de Concilio - Internal Dealing
Director's Dealing Classification · 100% confidence The document is a formal notification originating from Euronext Growth Milan, dated January 4, 2023. The 'Oggetto' (Subject) is 'Dealing'. The template used is titled 'Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.' Section 2 explicitly mentions 'Initial notification / Amendment' regarding transactions. This structure and content directly correspond to the reporting requirements for insider trading or director/executive share transactions. This matches the definition for Director's Dealing (DIRS).
2023-01-04 Italian
Farmacosmo: Il Consiglio Di Amministrazione Approva La Nomina Per Cooptazione Di Un Nuovo Consigliere Indipendente
Board/Management Information Classification · 98% confidence The document is an official communication from Farmacosmo S.p.A. dated December 29, 2022, filed under 'Informazione Regolamentata' (Regulated Information) on Euronext Growth Milan. The subject ('Oggetto') is the approval by the Board of Directors of the co-optation of a new Independent Director and the adoption of the Model 231/2001 and Code of Ethics. This announcement details significant changes in the company's governance structure (Board composition and internal controls). This clearly falls under the category of Board/Management Information (MANG), as it concerns the composition and structure of the Board of Directors. Although it touches upon governance, the primary focus is the change in management/board personnel and structure, making MANG the most precise fit over CGR (Governance Information) or RNS (General Regulatory Filing). The document is a press release/announcement, not the full report itself.
2022-12-29 Italian
Farmacosmo Acquista Il 67% Di Innovation Pharma, Proprietaria Di Due Farmacie Prosegue La Strategia Di Radicamento Delle Farmacie A Marchio Farmacosmo
Regulatory Filings Classification · 99% confidence The document is titled 'Informazione Regolamentata' (Regulated Information) and is explicitly labeled as a 'COMUNICATO STAMPA' (Press Release). The content details a significant corporate action: Farmacosmo's acquisition of a 67% stake in Innovation Pharma S.r.l. This type of announcement, detailing M&A activity, strategic expansion, and capital structure changes (though the primary focus is M&A), is typically released via a formal press release to the market. Since the document describes a takeover/acquisition proposal or completion, the most fitting category is 'M&A Activity' (TAR). It is not a full Annual Report (10-K), an Earnings Release (ER), or a general regulatory filing (RNS), as it concerns a specific, major transaction.
2022-12-21 Italian
Farmacosmo - Fabio de Concilio - Internal Dealing
Director's Dealing Classification · 100% confidence The document contains metadata indicating it is an 'Informazione Regolamentata' (Regulated Information) from Euronext Growth Milan, dated December 12, 2022. The 'Oggetto' (Subject) is 'Dealing'. The main body includes a 'Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.' It details the name of the person (Fabio de Concilio), their position ('Presidente del CdA e Amministratore Delegato' - Chairman of the Board and CEO), and confirms it is an 'Initial notification'. This content directly corresponds to the definition of Director's Dealing (insider trades by executives).
2022-12-12 Italian

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.